Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity
Seongman Bae, Jae‐Hoon Ko, Ju‐Yeon Choi, Woo Jung Park, So Yun Lim, Jin Young Ahn, Kyoung‐Ho Song, Kyoung Hwa Lee, Young Goo Song, Yong Chan Kim, Yoon Soo Park, Won Suk Choi, Hye Won Jeong, Shin‐Woo Kim, Ki Tae Kwon, Eun‐Suk Kang, Ah‐Ra Kim, Sundong Jang, Byoungguk Kim, Sung Soon Kim, Hee‐Chang Jang, Jun Yong Choi, Sung‐Han Kim, Kyong Ran Peck
Topics & Concepts
ReactogenicityHeterologousTiterImmunogenicityVaccinationAntibodyMedicineNeutralizing antibodyVirologyImmunologyBiologyGeneGeneticsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches